Clinical Trial Update: Lansoprazole Versus Mosapride for Functional Dyspepsia [Phase 4]

View source ↗

Summary

Phase 4 trial comparing lansoprazole and mosapride for functional dyspepsia has completed, evaluating their relative effectiveness for epigastric pain syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epigastric Pain Syndrome
• Functional Dyspepsia
• Postprandial Distress Syndrome

Drugs mentioned

• Lansoprazole (Lansoprazole)
• Mosapride (mosapride)

Snippet

Sponsor: Lotung Poh-Ai Hospital | Conditions: Functional Dyspepsia, Epigastric Pain Syndrome | Phase 4 | Status: COMPLETED